Creative Financial Designs’s PDS Biotechnology PDSB Stock Holding History

Creative Financial Designs’s Portfolio PDSB Stock Details PDSB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.81K	Hold	3,000	–	–	﹤0.01%	1792
2025 Q4	$2.31K	Hold	3,000	–	–	﹤0.01%	1662
2025 Q3	$3.03K	Hold	3,000	–	–	﹤0.01%	1636
2025 Q2	$3.99K	Hold	3,000	–	–	﹤0.01%	1565
2025 Q1	$3.57K	Hold	3,000	–	–	﹤0.01%	1557
2024 Q4	$4.89K	Buy	3,000 +950	+46%	+$2.51K	﹤0.01%	1427
2024 Q3	$7.83K	Hold	2,050	–	–	﹤0.01%	1264
2024 Q2	$6.01K	Buy	+2,050	New	+$6.56K	﹤0.01%	1284

Other funds holding PDSB

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

IWA

Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Creative Financial Designs's PDSB Position: Q1 2026 in Review

Creative Financial Designs held its PDS Biotechnology (PDSB) position steady in Q1 2026 at 3,000 shares worth $1.81K. The position accounts for ﹤0.01% of the portfolio, ranked #1792.

Creative Financial Designs first reported a position in PDSB in Q2 2024 and has held it in 8 quarters since. The position peaked at $7.83K in Q3 2024. 41 funds tracked by Wall St. Rank hold PDSB as of Q1 2026.

Creative Financial Designs held 3,000 shares of PDS Biotechnology worth $1.81K as of Q1 2026.
Creative Financial Designs left its PDS Biotechnology share count unchanged in Q1 2026.
PDS Biotechnology made up ﹤0.01% of Creative Financial Designs's portfolio in Q1 2026, its #1792 holding.
Creative Financial Designs first reported a position in PDS Biotechnology in Q2 2024 and has held it in 8 quarters since.
Creative Financial Designs's PDS Biotechnology position peaked at $7.83K in Q3 2024.
41 funds tracked by Wall St. Rank held PDS Biotechnology as of Q1 2026.

Based on Creative Financial Designs's 13F filing for Q1 2026, filed 13 Apr 2026.